Literature DB >> 20871469

Localized nasopharyngeal amyloidosis causing bilateral nasolacrimal duct obstruction.

Elena Geller1, Suzanne K Freitag, Nora V Laver.   

Abstract

A 62-year-old woman with a history of localized nasopharyngeal amyloidosis presented with bilateral complete nasolacrimal duct obstruction and 2 previous episodes of right dacryocystitis. Workup for systemic involvement was negative. Pathology was confirmed at the time of previous endonasal sinus surgery, showing submucosal amorphous deposition of Congo Red-positive material with apple-green birefringence. Computed tomography revealed extensive submucosal calcifications in the head and neck region, including bilateral nasolacrimal ducts. Localized amyloidosis is rare and most commonly involves the head and neck region. There is a previously reported case of nasolacrimal obstruction secondary to amyloidosis focal only to the nasolacrimal system, but we believe this to be the first report of localized nasopharyngeal amyloidosis to involve the nasolacrimal system.

Entities:  

Mesh:

Year:  2011        PMID: 20871469     DOI: 10.1097/IOP.0b013e3181e99e87

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  External dacryocystorhinostomy outcomes in patients with a history of dacryocystitis.

Authors:  Daniel R Lefebvre; Sonya Dhar; Irene Lee; Felicia Allard; Suzanne K Freitag
Journal:  Digit J Ophthalmol       Date:  2015-09-20

Review 2.  Amyloidosis of the Upper Aerodigestive Tract: Management of a Rare Disease and Review of the Literature.

Authors:  Thorsten Send; Jennifer L Spiegel; Goetz Schade; Annette Pantelis; Arno Olthoff; Friedrich Bootz; Martin Canis; Mark Jakob
Journal:  Dysphagia       Date:  2018-10-31       Impact factor: 3.438

3.  Localized amyloidosis affecting the lacrimal sac managed by endoscopic surgery: A case report.

Authors:  Xiao-Le Song; Jing-Yi Yang; Yu-Ting Lai; Jia-Ying Zhou; Jing-Jing Wang; Xi-Cai Sun; De-Hui Wang
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.